Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Vascular Surgeons (US)(?)

Council Members in this Study Group: 54

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

George Deitrick, MD
Assistant Professor of Surgery
MOUNT SINAI SCHOOL OF MEDICINE

George Deitrick, MD, is the Director of Wound Healing Program and Spinal Cord Injury Unit at Bronx Veterans Affairs Medical Center in New York. He is a General Surgeon and Assistant Professor of Surgery at Mount Sinai School of Medicine in New York City. Dr. Deitrick has over 20 years of experience...

Jeffrey Ballard, MD, FACS, Vascular Surgeon, St.joseph Hospital of Orange Inc.Jeffrey Ballard, MD, FACS
Vascular Surgeon
St.joseph Hospital of Orange Inc.

Jeffrey Ballard, MD, FACS, is a Vascular and Endovascular Surgeon who practices at St. Joseph Hospital of Orange, California. He also has a appointment as Clinical Professor of Surgery at University of California, Irvine. Dr. Ballard offers comprehensive care for all problems of arterial and venous...

Jeffrey Gosin, M.D., Attending Surgeon and Chief of Vascular Surgery, Shore Memorial HospitalJeffrey Gosin, M.D.
Attending Surgeon and Chief of Vascular Surgery
Shore Memorial Hospital

Jeffrey Gosin, MD, is a Vascular and General Surgeon with Jersey Shore Surgical Group in New Jersey. He is an Attending Surgeon and Chief of Vascular Surgery at Shore Memorial Hospital and Medical Director of the Cardiovascular Institute, a multidisciplinary department which includes vascular surgeons,...

Eric Choi, MD
Assistant Professor of Surgery and Radiology
Washington University in St. Louis-School of Medicine

Eric Choi, MD, is an Associate Professor of Surgery and Radiology at Washington University School of Medicine, Missouri. Dr. Choi has expertise in the treatment of wide variety of vascular diseases including aortic aneurysm, carotid artery disease, peripheral arterial diseases, and venous diseases....

Fred Weaver, MD, MMM, Professor of Surgery, University of Southern California Keck School of MedicineFred Weaver, MD, MMM
Professor of Surgery
University of Southern California Keck School of Medicine

Fred Weaver, MD, is a Professor of Surgery at Keck School of Medicine of USC. He is Division Head of Vascular Surgery and Endovascular Therapy and Medical Director at the Noninvasive Vascular Laboratories at USC University Hospital in California. Dr. Weaver’s main interests include endovascular technology...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Cook Vena Caval Filter Sets Standard for Retrievable Filters | 04-09-2007
Author: Jeffrey Gosin, M.D., Attending Surgeon and Chief of Vascular Surgery, Shore Memorial Hospital

New data from Cook shows 94% success rate in retrieving a temporary vena caval filter at 12 weeks post implant. This new data confirms what many of us have believed; that retrievable filters can successfully and safely be removed months after implantation.

An improvement in anti-platelet therapy | 11-24-2006
Author: GLG Expert Contributor

This is important for the following reasons 1) This drug would provide more rapid anti-platelet action, in critical conditions such as acute coronary syndrome2) It will provide more reliable platelet inhibition compared to current therapy

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Owner
  • Partner
  • President
  • Physician - Fellow

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T01:45:24.617